A Randomised Controlled Trial of a Weight Loss Maintenance Program for Adults With Obesity: The WLM3P Study

Exclusion Criteria

• •Pregnant, breastfeeding or planning to become pregnant within the study period.
• •Subjects with chronic inflammatory bowel disease (clinical history of Crohn's disease, ulcerative colitis, irritable colon and diverticulitis)
• •Subjects with hormonal or thyroid pathology (hyper and hypothyroidism where TSH is not within normal range)
• •Subjects with renal impairment
• •Subjects with chronic liver disease other than non-alcoholic hepatic steatosis
• •Subjects with autoimmune diseases and/or chronic use of corticosteroids.
• •Use of weight loss medications/other nutritional supplements
• •Subjects with psychiatric or neurological illness
• •Subjects sensitive to any component of supplements
• •Subjects with surgery or hospitalization in the last 30 days
• •Subjects prescribed with 5 or more drugs
• •Previous attempt to lose weight in the last month and/or weight loss of more than 10kg in the 3 months prior to the start of the study
• •Subjects with excessive alcohol consumption (self-reported: drinking more than 3 glasses of wine/day - or equivalent)
• •Subjects with history of drug, alcohol or other substances abuse.
• •Eating behavior disorders
• •Pacemaker carrier
• •Urinary incontinence
• •Vegetarians or vegans
• •Subjects underwent bariatric surgery
• •Type 1 or type 2 diabetes mellitus
• •Altered blood clotting
• •Severe heart failure